.svg)
Type 2 Diabetes Study
Locations: Weslaco
Type 2 diabetes is a prevalent condition affecting 30 million Americans, characterized by the body's ineffective use of insulin, leading to elevated blood sugar levels. Managing type 2 diabetes often requires lifestyle changes, regular blood sugar monitoring, and medications, including injectable GLP-1 treatments like semaglutide or tirzepatide.
Texas Valley Clinical Research is currently seeking adults aged 18 to 75 who have been diagnosed with type 2 diabetes and have been taking a GLP-1 injectable medication (such as semaglutide or tirzepatide) for at least 3 months with suboptimal blood sugar control to participate in related studies.
Please fill out the form today to start your journey toward better health!
Type 2 diabetes is a prevalent condition affecting 30 million Americans, characterized by the body's ineffective use of insulin, leading to elevated blood sugar levels. Managing type 2 diabetes often requires lifestyle changes, regular blood sugar monitoring, and medications, including injectable GLP-1 treatments like semaglutide or tirzepatide.
Texas Valley Clinical Research is currently seeking adults aged 18 to 75 who have been diagnosed with type 2 diabetes and have been taking a GLP-1 injectable medication (such as semaglutide or tirzepatide) for at least 3 months with suboptimal blood sugar control to participate in related studies.
Please fill out the form today to start your journey toward better health!
Learn more today!
Interested in learning more? Call 956-276-8969 or submit the form below, and a dedicated member of our team will reach out to you shortly.
